Skip to main content
Michael Nicholl, MD, General Surgery, San Antonio, TX

MichaelNichollMDFACS

General Surgery San Antonio, TX

Melanoma, Pancreas, Surgical Oncology (Other than Breast)

Section Chief

Dr. Nicholl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nicholl's full profile

Already have an account?

  • Office

    7400 Merton Minter Blvd
    San Antonio, TX 78229
    Phone+1 210-617-5300

Education & Training

  • John Wayne Cancer Institute
    John Wayne Cancer Institute2006 - 2009
  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsResidency, Surgery, 1999 - 2006
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 1999
  • University of Pittsburgh
    University of PittsburghBS, Physics, 1991 - 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • TX State Medical License
    TX State Medical License 2014 - 2025
  • WI State Medical License
    WI State Medical License 2000 - 2019
  • MO State Medical License
    MO State Medical License 2009 - 2015
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Outstanding Patient Educator Award University of Missouri, 2011
  • Merit Award ASCO Cancer Foundation, 2008
  • Golden Scalpel Award for Outstanding Chief Resident Medical College of Wisconsin, 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • IL-9 inhibits melanoma cell growth through up regulation of p21 and TRAIL  
    Fang Y, Chen X, Mohamud AO, Qin C, Bai Q, Cook KM, Herrick EJ, Ledgerwood CL, Davis MR, Nicholl MB, J Surg Oncol, 1/1/2015
  • Solid pseudopapillary tumor of the pancreas with massive cystic degeneration: source of diagnostic confusion  
    Ostermeyer AJ, Nicholl MB., Pancreat Disorders and Therapy, 1/1/2014
  • IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition apoptosis: evidence for a role as an autocrine growth factor  
    Nicholl MB, Ledgerwood CL, Chen X, Bai Q, Qin C, Cook KM, Herrick EJ, Diaz-Arias A, Moore BJ, Fang Y., Cytokine, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis
    Nicholl MB, Pancreas Club, Chicago, IL, 1/1/2014
  • IL-35 promotes melanoma growth by promoting proliferation and inhibiting apoptosis.
    Nicholl MB, Society of Surgical Oncology, National Harbor, MD, 1/1/2013
  • Assessment of a novel immunological biomarker SNP panel from a phase III trial of Bacillus Calmette-Guerin (BCG) adjuvant treatment in stage III melanoma patients
    Nicholl MB, American Society of Clinical Oncology, Chicago, IL, 1/1/2012
  • Join now to see all

Lectures

  • Alimentary Tract II Session 
    Chicago, IL - 1/2./2012
  • Does specialized surgical training increase lymph node yield in colon cancer? 
    Santa Barbara, CA - 1/17/2009
  • Restored immune response to an MHC-II restricted antigen in tumor-bearing hosts after elimination of regulatory T cells 
    New Orleans, LA - 1/1./2003
  • Join now to see all

Press Mentions

  • Unbearable Grief: Parents Want Answers over Their Baby's Death
    Unbearable Grief: Parents Want Answers over Their Baby's DeathOctober 27th, 2020
  • Australia's Silent Tragedy: A Stubbornly High Stillbirth Rate and the Push to Change It
    Australia's Silent Tragedy: A Stubbornly High Stillbirth Rate and the Push to Change ItApril 25th, 2020

Professional Memberships